|
TBC1D2B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.879900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.397800E-03 |
| Normal-vs-Stage2 |
9.581000E-04 |
| Normal-vs-Stage3 |
3.260500E-02 |
| Normal-vs-Stage4 |
5.187800E-02 |
| Stage1-vs-Stage2 |
1.082010E-01 |
| Stage1-vs-Stage3 |
9.023600E-01 |
| Stage1-vs-Stage4 |
8.827800E-01 |
| Stage2-vs-Stage3 |
1.430570E-01 |
| Stage2-vs-Stage4 |
1.554030E-01 |
| Stage3-vs-Stage4 |
9.644200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.439600E-03 |
| Normal-vs-AfricanAmerican |
8.811200E-01 |
| Normal-vs-Asian |
3.259400E-01 |
| Caucasian-vs-AfricanAmerican |
7.350500E-02 |
| Caucasian-vs-Asian |
2.028000E-01 |
| AfricanAmerican-vs-Asian |
5.034400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.775500E-03 |
| Normal-vs-Female |
6.378900E-03 |
| Male-vs-Female |
8.648200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.964120E-02 |
| Normal-vs-Age(41-60Yrs) |
2.093900E-02 |
| Normal-vs-Age(61-80Yrs) |
5.964500E-04 |
| Normal-vs-Age(81-100Yrs) |
8.678400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.147600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.386220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.589000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.061820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.715400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.178230E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.020600E-01 |
| Classical-VS-Follicular |
4.48649994932993E-09 |
| Classical-VS-Other |
7.272000E-02 |
| Classical-VS-Normal |
1.215990E-01 |
| Tall-VS-Follicular |
1.335500E-03 |
| Tall-VS-Other |
1.226430E-01 |
| Tall-VS-Normal |
2.085600E-01 |
| Follicular-VS-Other |
8.955000E-01 |
| Follicular-VS-Normal |
8.67760000522466E-08 |
| Other-VS-Normal |
2.363700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.043740E-03 |
| Normal-vs-N1 |
5.785000E-04 |
| N0-vs-N1 |
4.104600E-01 |
|
|
